Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
αv Integrins regulate germinal center B cell responses through noncanonical autophagy
Fiona Raso, … , Adam Lacy-Hulbert, Mridu Acharya
Fiona Raso, … , Adam Lacy-Hulbert, Mridu Acharya
Published July 12, 2018
Citation Information: J Clin Invest. 2018;128(9):4163-4178. https://doi.org/10.1172/JCI99597.
View: Text | PDF
Research Article Immunology

αv Integrins regulate germinal center B cell responses through noncanonical autophagy

  • Text
  • PDF
Abstract

Germinal centers (GCs) are major sites of clonal B cell expansion and generation of long-lived, high-affinity antibody responses to pathogens. Signaling through TLRs on B cells promotes many aspects of GC B cell responses, including affinity maturation, class switching, and differentiation into long-lived memory and plasma cells. A major challenge for effective vaccination is identifying strategies to specifically promote GC B cell responses. Here, we have identified a mechanism of regulation of GC B cell TLR signaling, mediated by αv integrins and noncanonical autophagy. Using B cell–specific αv-KO mice, we show that loss of αv-mediated TLR regulation increased GC B cell expansion, somatic hypermutation, class switching, and generation of long-lived plasma cells after immunization with virus-like particles (VLPs) or antigens associated with TLR ligand adjuvants. Furthermore, targeting αv-mediated regulation increased the magnitude and breadth of antibody responses to influenza virus vaccination. These data therefore identify a mechanism of regulation of GC B cells that can be targeted to enhance antibody responses to vaccination.

Authors

Fiona Raso, Sara Sagadiev, Samuel Du, Emily Gage, Tanvi Arkatkar, Genita Metzler, Lynda M. Stuart, Mark T. Orr, David J. Rawlings, Shaun W. Jackson, Adam Lacy-Hulbert, Mridu Acharya

×

Figure 9

Deletion of αv enhances antibody response to influenza virus.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of αv enhances antibody response to influenza virus.
(A and B) ...
(A and B) Serum anti-PR/8 IgG titers in control and αv-CD19 mice immunized with 10 μg of inactivated H1N1 PR/8 (A) and (B) boosted at day 57 with 5 μg inactivated PR/8. (C) PR/8-specific plasma cells enumerated by ELISpot in BM cells from control (Con) and αv-CD19 mice harvested at day 7 after boost. (D) HAI activity in sera from control and αv-CD19 mice at day 21 after PR/8 immunization. (E and F) Serum antibody titers against HA from H1N1 PR/8 (E) or H1N1 Cal/09 (F) in control and αv-CD19 mice at day 7 after boost with inactivated PR/8. (G) Anti-Cal/09 HA titer normalized to anti-PR/8 HA titer. (H and I) Serum antibody titers against HA from PR/8 (H) or Cal/09 (I) in control and αv-CD19 at day 51 after immunization with inactivated PR/8 (10 μg) in imiquimod-SE (10 μg). (J) Anti-Cal/09 HA titer normalized to anti-PR/8 HA titer for mice immunized with PR/8 in imiquimod-SE. (K) Survival of control and αv-CD19 mice following intranasal infection with PR/8 (n ≥ 5 mice/group). (L) Anti-PR8 HA titers from surviving mice at day 7 after infection. All data points represent individual mice with mean shown. P values of less than 0.05 are shown (Mann-Whitney-Wilcoxon test for antibody titers or Mantel-Cox test for survival curves).*P < 0.05; **P < 0.005. Samples below the level of detection are indicated as not detected. For all data, similar results were seen in at least 3 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts